快速基因组测序:新生儿重症监护情境下新技术的知情同意
本文讨论在NICU中为危重婴儿开展快速基因组测序(rGS)时面临的知情同意挑战。rGS可快速指导精准治疗并可能挽救生命,但也可能诊断出严重限制生命的疾病,引发撤除生命支持治疗的讨论。文章通过一例父母均无法提供知情同意的病例,分析基因组测序与其他基因检测的差异、检测前咨询的关键作用、NICU的同意范式以及父母同意与患儿利益之间的伦理互动。
要点
- rGS在危重婴儿中临床效用明确,有呼吁将其作为NICU一线检测。
- rGS可快速指导精准治疗,但也可能诊断严重限制生命的疾病。
- 检测前咨询对促进知情同意和帮助父母准备多种可能结果至关重要。
核心结论
- 在NICU开展rGS需重视检测前咨询,以促进知情同意并帮助父母应对多种可能结果。
- rGS因对患者和家庭成员的长期影响,其同意范式与NICU常规干预不同。
- 父母同意与患儿利益之间的伦理互动需在个案中权衡,本中心已有相应解决方式。
研究设计与样本
- 本文为病例讨论与伦理分析,呈现一例父母均无法提供知情同意的病例。
- 讨论基于NICU中rGS的临床效用、知情同意挑战及伦理框架。
主要发现
- rGS可快速启动精准治疗,具有潜在挽救生命的价值。
- 在许多患者中rGS导致严重且限制生命的疾病诊断,促使与家庭讨论撤除生命支持治疗。
- rGS信息的复杂性及NICU父母情绪高涨,给知情决策带来显著挑战。
- 基因组测序与其他类型基因检测存在重要差异,检测前咨询在促进知情同意中起关键作用。
临床怎么用
- 在NICU开展rGS前应进行检测前咨询,帮助父母理解检测的复杂性及可能结果。
- 当父母无法提供知情同意时,治疗团队需依据患儿最佳利益原则决策是否进行rGS。
- 应认识到rGS与NICU常规干预不同,需考虑其对患者和家庭成员的长期影响。
局限性
- 本文为单中心病例讨论与伦理分析,未报告系统研究数据或样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The clinical utility of rapid genome sequencing (rGS) in critically unwell infants has been consistently demonstrated, and there are calls for rGS to be implemented as a first-line test in the NICU. A diagnosis from rGS can enable rapid initiation of precision treatment, making it potentially lifesaving. However, in many patients rGS leads to the diagnosis of severe and life-limiting conditions, prompting discussion with families about withdrawal of life-sustaining treatment. The complexity of information about rGS, together with the heightened emotions of parents in the NICU, poses significant challenges for informed decision making in this context. We present a case where both parents are unable to provide informed consent, and the treating team must decide whether to proceed with rGS. Our discussion highlights the important differences between genome sequencing and other types of genetic testing, and the crucial role played by pre-test counseling in facilitating informed consent and preparing parents for a range of possible outcomes. We then discuss the consent paradigms at play in NICUs; whereas admission generally comes with an understanding that the treating team will perform interventions thought to be in the best interest of the child, rGS is substantially different because of its long-term implications for patients and family members. Finally, we look at the ethical interplay between parental consent and the interests of the child. We conclude by showing how cases like this are resolved at our tertiary center and how they may be resolved differently in future.
引用
- Lynch F, Prentice T, Gillam L, et al. Rapid Genome Sequencing: Consent for New Technologies in the Neonatal Intensive Care Context. Pediatrics. 2022. PMID: 36443237. doi:10.1542/peds.2022-058222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。